Thromboreductin 1 mg, Kapseln

7680590310036 CH-59031 Kapseln
Thromboreductin 1 mg, Kapseln
Thromboreductin 1 mg, Kapseln
Thromboreductin 1 mg, Kapseln
1 / 3
google

Article details

Package size
100
Selling units
100
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
08/11/2023
Patient information leaflet
Français
08/11/2023
Patient information leaflet
Italien
08/11/2023
Summary of Product Characteristics
Allemand
08/11/2023
Summary of Product Characteristics
Français
08/11/2023
Summary of Product Characteristics
Italien
08/11/2023

Detailed composition

Substance Quantity Type Category
(N/A)
1.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
93.33 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK

Reimbursement information

Public price
CHF 367.90
Specialties list
Yes
Generic
No
SL addition date: 01/04/2011

Authorization holder

OrPha Swiss GmbH

8700 Küsnacht ZH

Authorization information

Swissmedic authorization number
59031
Drug name
Thromboreductin, Kapseln
Galenic form
KAHA
ATC Code
L01XX35
Authorization status
Z
Dispensing category
B
First authorization
15/04/2010
Authorization expiration date
31/12/9999
IT Number
07.16.4.
Domain
Human medicine
Field of application
Behandlung der essentiellen Thrombozythämie

Package details

Description (FR)
THROMBOREDUCTIN caps 1 mg bte 100 pce
Description (DE)
THROMBOREDUCTIN Kaps 1 mg Ds 100 Stk
Market launch
15/04/2010
Market withdrawal
01/10/2025
Narcotic (BTM)
No

Other package sizes (2)

THROMBOREDUCTIN caps 0.5 mg bte 42 pce
42 KAP
GTIN: 7680590310012
View
THROMBOREDUCTIN caps 0.5 mg bte 100 pce
100 KAP
GTIN: 7680590310029
View